Histopathology and Genetic Causes of Primary Aldosteronism in Young Adults.
CYP11B2
aldosterone-producing adenoma
primary aldosteronism
somatic mutation
young adults
Journal
The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362
Informations de publication
Date de publication:
18 08 2022
18 08 2022
Historique:
received:
26
12
2021
pubmed:
3
7
2022
medline:
23
8
2022
entrez:
2
7
2022
Statut:
ppublish
Résumé
Due to its rare incidence, molecular features of primary aldosteronism (PA) in young adults are largely unknown. Recently developed targeted mutational analysis identified aldosterone-driver somatic mutations in aldosterone-producing lesions, including aldosterone-producing adenomas (APAs), aldosterone-producing nodules (APNs), and aldosterone-producing micronodules, formerly known as aldosterone-producing cell clusters. To investigate histologic and genetic characteristics of lateralized PA in young adults. Formalin-fixed, paraffin-embedded adrenal tissue sections from 74 young patients with lateralized PA (<35 years old) were used for this study. Immunohistochemistry (IHC) for aldosterone synthase (CYP11B2) was performed to define the histopathologic diagnosis. Somatic mutations in aldosterone-producing lesions were further determined by CYP11B2 IHC-guided DNA sequencing. Based on the CYP11B2 IHC results, histopathologic classification was made as follows: 48 APAs, 20 APNs, 2 multiple aldosterone-producing nodules (MAPN), 1 double APN, 1 APA with MAPN, and 2 nonfunctioning adenomas (NFAs). Of 45 APAs with successful sequencing, 43 (96%) had somatic mutations, with KCNJ5 mutations being the most common genetic cause of young-onset APA (35/45, 78%). Of 18 APNs with successful sequencing, all of them harbored somatic mutations, with CACNA1D mutations being the most frequent genetic alteration in young-onset APN (8/18, 44%). Multiple CYP11B2-expressing lesions in patients with MAPN showed several aldosterone-driver mutations. No somatic mutations were identified in NFAs. APA is the most common histologic feature of lateralized PA in young adults. Somatic KCNJ5 mutations are common in APAs, whereas CACNA1D mutations are often seen in APNs in this young PA population.
Identifiants
pubmed: 35779252
pii: 6627588
doi: 10.1210/clinem/dgac408
pmc: PMC9761569
doi:
Substances chimiques
CACNA1D protein, human
0
Calcium Channels, L-Type
0
G Protein-Coupled Inwardly-Rectifying Potassium Channels
0
KCNJ5 protein, human
0
Aldosterone
4964P6T9RB
Cytochrome P-450 CYP11B2
EC 1.14.15.4
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2473-2482Subventions
Organisme : NIDDK NIH HHS
ID : K23 DK121888
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR001879
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK043140
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL130106
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK106618
Pays : United States
Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Hypertension. 2019 Apr;73(4):885-892
pubmed: 30739536
Sci Rep. 2016 Jan 27;6:19546
pubmed: 26815163
Hypertension. 2021 Sep;78(3):738-746
pubmed: 34024122
Nat Genet. 2013 Sep;45(9):1050-4
pubmed: 23913001
J Clin Endocrinol Metab. 2008 Sep;93(9):3266-81
pubmed: 18552288
Clin Endocrinol (Oxf). 2015 Dec;83(6):779-89
pubmed: 26252618
Eur J Endocrinol. 2019 Nov;181(5):K37-K41
pubmed: 31491746
Hypertension. 2002 Dec;40(6):892-6
pubmed: 12468575
J Clin Endocrinol Metab. 2016 Mar;101(3):999-1007
pubmed: 26765578
J Clin Endocrinol Metab. 2018 Oct 1;103(10):3869-3876
pubmed: 30085035
High Blood Press Cardiovasc Prev. 2014 Mar;21(1):71-5
pubmed: 24464387
Mol Cell Endocrinol. 2014 Mar 5;383(1-2):111-7
pubmed: 24325867
Nat Genet. 2013 Apr;45(4):440-4, 444e1-2
pubmed: 23416519
Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):E4591-9
pubmed: 26240369
Am J Hypertens. 2020 Feb 22;33(2):124-130
pubmed: 31637427
Mol Cell Endocrinol. 2017 Feb 5;441:134-139
pubmed: 27514282
J Clin Endocrinol Metab. 2015 Aug;100(8):E1089-95
pubmed: 26066531
J Am Coll Cardiol. 2017 Apr 11;69(14):1811-1820
pubmed: 28385310
Science. 2011 Feb 11;331(6018):768-72
pubmed: 21311022
J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2087-e2095
pubmed: 33507307
Surgery. 2004 Dec;136(6):1227-35
pubmed: 15657580
J Clin Endocrinol Metab. 2020 Sep 1;105(9):
pubmed: 32516371
Nat Genet. 2013 Sep;45(9):1055-60
pubmed: 23913004
Horm Metab Res. 2015 Dec;47(13):953-8
pubmed: 26566104
J Clin Endocrinol Metab. 2021 Jan 1;106(1):42-54
pubmed: 32717746
Hypertension. 2020 Mar;75(3):645-649
pubmed: 31983310
J Clin Endocrinol Metab. 2016 May;101(5):1889-916
pubmed: 26934393
Hypertension. 2018 Sep;72(3):632-640
pubmed: 30354756
PLoS One. 2012;7(7):e41926
pubmed: 22848660
Endocr J. 2011;58(9):711-21
pubmed: 21828936
Hypertension. 2020 Apr;75(4):1034-1044
pubmed: 32114847
Hypertension. 2012 Mar;59(3):592-8
pubmed: 22275527
Eur J Endocrinol. 2021 May 21;185(1):R1-R11
pubmed: 33900205
J Clin Endocrinol Metab. 2012 May;97(5):E819-29
pubmed: 22442279
J Endocr Soc. 2017 May 12;1(7):787-799
pubmed: 29264530
Mol Cell Endocrinol. 2015 Aug 15;411:146-54
pubmed: 25958045
J Clin Endocrinol Metab. 2020 Nov 1;105(11):
pubmed: 32844168
Sci Rep. 2017 Jan 19;7:39121
pubmed: 28102204
Eur J Endocrinol. 2016 Aug;175(2):K1-6
pubmed: 27165862
Hypertension. 2014 Aug;64(2):354-61
pubmed: 24866132
Hypertension. 2015 Nov;66(5):1014-22
pubmed: 26351028